Last updated 2026-07-26
- Went public on CSE (VIVI), Oct 2025
- Raised $5.4M Follow-on PO, Sep 2025
- Raised $1.8M Follow-on PO, Oct 2025
Total raised
$12.0M
Last: Public Offering 2025-10
Stage
Public
Founded
2014
Headcount
22
HQ
Tel Aviv-Yafo, Israel
Sector
Health Tech & Life Sciences
About
TempraMed is a medical device company that has developed a revolutionary, first-of-its-kind, medication protection and storage device for temperature-regulated medication. The company's mission is to safeguard the effectiveness of life-saving medications by developing patented, FDA-registered, space-grade thermal insulation devices that work 24/7 without batteries or external power. TempraMed's products integrate regenerative phase-change heat-absorbing materials with thermal insulation and a low-power, user-actuated visual temperature-status indicator. The company aims to provide last-mile control management for all injectable and temperature-sensitive pharmaceuticals, helping patients manage and control their medications and live safer, more spontaneous lives.
Funding history · 6 rounds · $12.0M total
2025-10
Follow-on PO
$1.8M
2025-09
Follow-on PO
$5.4M
2025-09
PIPE
$1.8M
2024-02
Grant
$330K
2021-11
A Round
$1.8M
2021-11
Grant
$889K
Headcount over time
From 4 (2019-05) to 18 (2026-03) · +14 (+350%) · 8 points · source: Finder history + radar grounding
Q&A
- What is TempraMed's primary business?
- TempraMed develops, manufactures, and markets innovative personal storage solutions for injectable medications, providing temperature control without the need for a power source or human intervention.
- When did TempraMed go public and on which exchange?
- TempraMed went public on the CSE in October 2025, trading under the ticker VIVI.
- How many employees does TempraMed currently have?
- TempraMed has between 11-50 employees.
- What is TempraMed's market capitalization?
- TempraMed's market capitalization is $40,493,359.
- What is a recent strategic partnership for TempraMed in North America?
- In June 2026, TempraMed expanded its strategic partnership with McKesson Medical-Surgical to accelerate North American growth and launch its full portfolio across B2B channels.
- Has TempraMed expanded its intellectual property recently?
- Yes, in May 2026, TempraMed announced a granted Indian Design Patent for its VIVI Cap Smart Product. Additionally, in March 2026, TempraMed strengthened its global intellectual property position with a granted Chinese patent for its newest product, VIVI Box.
- What new product did TempraMed launch in January 2026?
- In January 2026, TempraMed launched a new product called "VIVI Med," aimed at unlocking new growth opportunities in high-value biologics and injectable medications.
- What is TempraMed's strategy for market penetration in Israel?
- In February 2026, TempraMed partnered with Super-Pharm, Israel's leading pharmacy chain, to commence a national product roll-out strategy. This followed a strategic agreement in December 2025 with Maccabi Healthcare Services, covering over 2.8 million patients.
Team · 1
Ron Nagar
Founder · Founder and CEO
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesMedical DevicesMedical Treatment & Therapeutics
Technologies
Materials & Substances
Target customers
Healthcare & Life SciencesHealthcareProvidersPatientsLaboratoriesMedical Devices IndustryMedical ProductsLife SciencesBiotechnologyPharmaceuticals
Business model
B2CB2BB2B2C
Highlights
1 PatentsVerified
Tags
pharma-companieschronic-diseasesupply-chainpatientspharmaceuticalsdiabetesmonitoringmedical-productstype-2-diabetescoolingmedical-devicesstorage
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
Identifiers & details
| Founded | 2014 |
|---|---|
| Employees (exact) | 22 |
| Offices | Sammamish |
| Market cap | $40.5M |
| Status reason | Public on CSE on Oct, 2025; |
Acquisitions & public offerings
| Type | Date | Exchange | Ticker | Amount |
|---|---|---|---|---|
| IPO | 2025-10 | CSE | VIVI |
Radar intelligence
Publications (Crossref)
| Works | 3 |
|---|
Web history (Wayback)
| Domain | tempramed.com |
|---|
Israeli Companies Registrar (רשם החברות / ICA)
| Registrar # (ח.פ.) | 515452654 |
|---|---|
| Status | פעילה |
| Corp type | ישראלית חברה פרטית |
| Incorporated | 2016-05-10 |
| Purpose | לעסוק בכל עיסוק חוקי |
| Liability | מוגבלת |
| In violation (unfiled) | no |
| Last annual report | 2025 |
| Active charges / liens | 0 |
| Registry events | 6 — violation (1), annual_report (2), shares_capital (2), people (1) |
| Registered address | הא באייר 14 תל אביב - יפו |
Recent registry events
| Date | Event |
|---|---|
| 2025-12-18 | עדכון הפרה |
| 2025-12-18 | דו~ח שנתי-הסרת דירקטור |
| 2025-12-18 | דו~ח שנתי-עדכון כתובת |
| 2025-12-17 | הקצאת מניות |
| 2025-12-17 | העברת מניות |
| 2026-06-16 | עדכון בעלי תפקידים |